CleverSkin Technologies Limited

Website
HealthTech,BioTech

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Vadzim Tsitou, Dr John Butler
Seed
United Kingdom
HealthTech, BioTech
2024
CleverSkin will generate revenue from sales of single-use advanced wound dressings to hospitals, clinics, pharmacies, emergency services and defence organisations, primarily through distributors and procurement contracts. Additional revenue will come from licensing, technology-transfer and local-manufacturing partnerships, including upfront fees, supply income and royalties. We create value by reducing dressing changes, clinical workload and the total cost of wound care.

CleverSkin is a London MedTech developing a self-forming, two-component advanced wound dressing. Activated in-pack and applied without equipment, it conforms to complex wound geometry. Beyond concept, we have functional samples, prior R&D and clinical-use evidence, and an FDA-first scale-up plan.